🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⁦Rosalba Miceli⁩ presenting at the annual meeting of ⁦Italian Sarcoma Group⁩ about predicting tools in #sarcoma . She is the biostat behind #sarculator and partnering with ⁦Dario Callegaro⁩ for current and future tooks! Great promise ahead! ⁦CTOS⁩ ⁦

Forge your own worldview. To be indispensable, do not be the prisoner of someone else's ideas. And there lies the ultimate and terrifying reality: No one is truly indispensable. From-within #offline richard horton The Lancet

#MiamiNights ASCO #ASCO23 is a wrap! Epic night with so many friends Alessandro Gronchi Silvia Stacchiotti Roberta Sanfilippo Chiara Fabroni vicki keedy Marco Fiore, MD, FACS, FEBSh Elizabeth Davis Nam Bui Carmen Calfa, MD Gina Z. D'Amato, MD. Patrick Schöffski Dr. Estela Rodriguez Priscila Barreto Coelho, MD gilberto lopes

linkedin.com/feed/update/ur…

x.com/GDefiner/statu…

x.com/IstTumori/stat…

Essere citati da Harrell è un onore x.com/f2harrell/stat…

Our study published on JAMA Surgery about prophylactic Salpingo-Oophorectomy and Survival in BRCA1/2-Mutant Breast Cancer patients - ascopost.com/news/october-2…

Great start yesterday for the #Sarcoma #Accelerator annual meeting! Great scientific program & discussion👏 and networking. Thanks Robin Lewis Jones Paul Huang Lab Sandro Pasquali and all the Accelerators!

Fantastic science & collaborative research at #Sarcoma Accelerator Consortium meeting in Milan 🇮🇹🤓 A wonderful multidisciplinary group building an innovative platform of tools, models & datasets to design better therapies for our patients Looking forward to 2025 meeting in 🇪🇸!

Excellent talk from Prof Paolo G Casali on the controversial world of surrogate endpoints in clinical research today!! 📌 Are they reliable indicators of treatment efficacy or just a shortcut? Great debate at #ISG annual meeting ✔️ #sarcoma Alessandro Gronchi antonella brunello Rosalba Miceli

Thanks to ASCO and AIOM for having invited me to participate again as faculty member to this great course x.com/AIOMtweet/stat…

A model that honestly says it doesn’t know what will happen is not necessarily a bad model. Even with all the data, many things are hard to predict. We have to stop believing data is enough.

🚨Our latest paper evaluating #proteomic signatures with the Sarculator nomogram to predict high-risk #sarcoma patients is out in CancerMedicine! This is a wonderful collaboration with Sandro Pasquali Rosalba Miceli Alessandro Gronchi Istituto Tumori Read more here dx.doi.org/10.1002/cam4.7…

Milan Istituto Tumori crew at #CTOS2024 Chirurgia dei Sarcomi INT 😀

Great #CTOS 2024 Annual Meeting in San Diego! Always a unique time for ideas exchange and meeting new and old friends from all around the world. Looking forward for future steps in #sarcoma research! #PUSH Alessandra Merlini Silvia Stacchiotti William Tap Tom Wei-Wu Chen Herbert Loong, MBBS, FASCO Alessandro Gronchi

#CTOS2024 coming to an end 😅 with Stefano Radaelli Rosalba Miceli Daniela Salvatore farewell seafood lunch after caching up again with #travellingsurgeon Catherine Sarre 🌍🌎🌏 UofT Surgical Oncology Peter Mac Cancer Centre Istituto Tumori Grupo Mexicano de Sarcomas

Honored to have attended the ASCO - AIOM Clinical Research Course in Rome—valuable insights to advance oncology research in LATAM! #Oncology #ClinicalResearch Massimo Di Maio Dario Trapani Bishal Gyawali, MD, PhD, FASCO Omar Abdihamid Hatice Bölek Muharrem Coşkunpınar Leandro Jonata Oliveira

Orgogliosissima!!!